Researchers at Oxford University are working with great care, and due haste, to help the roll-out of the vaccines for coronavirus. A swift, effective roll-out could provide an exit strategy for the pandemic and save lives. While we understand the interest, we ask that the media do not continue to contact researchers while this critical work is underway so that they can focus on these efforts.
Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine
25th June 2021
Press Mailing list
If you would like to receive updates about the covid vaccine trials, please sign up to our mailing list. This list is for press contacts only.
Sign up to press mailing list
The Medical Sciences Division Data Privacy Notice describes how we collect and use your personal data submitted to us online, by email, on paper or face-to-face, in accordance with the General Data Protection Regulation (GDPR) and associated data protection legislation.
Contact Us (Press only)
This information is for Press enquiries only. If you would like to find out more about participating in the trial, please click here.
Please read the press releases above before contacting us as your question may be answered there. For further enquiries, please contact the University of Oxford Press Office. We will try to respond to your message (if appropriate) as soon as we can, however we are unable to respond to all messages and responses may be delayed due to the nature of the current situation.